Merck & Co (MRK)
65.61
-0.18 -0.27%
NYSE
Sep 21, 16:58
Delayed 2m
USD
View All Key Stats
MRK Key Stats
| Income Statement | |
| Revenue (TTM) | 40.02B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.84 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.086B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.98% |
| Profit Margin (Quarterly) | 19.60% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.87% |
| Price and Valuation | |
| Market Cap | 178.94B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.541 |
| PE Ratio (TTM) | 35.66 |
| Price to Book Value | 4.534 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.6306 |
| Free Cash Flow (Quarterly) | 2.924B |
| Return on Equity (TTM) | 12.32% |
View All MRK News
MRK News
-
WireHeadlineTime (ET)
-
SA Breaking News09/21 16:18
-
Yahoo09/20 20:46
-
Yahoo09/20 15:50
-
Yahoo09/20 13:10
-
Business Wire09/19 07:00
-
MT Newswires09/19 06:40
-
Yahoo09/18 10:19
-
Yahoo09/18 09:42
-
SA Breaking News09/16 08:00
-
PR Newswire09/15 17:21
View All Events
MRK Events
| Date | Type | Description |
|---|---|---|
| 09/14/2017 | Dividends | Amount: 0.47, Declared Date: Jul 26 2017, Pay Date: Oct 06 2017 |
| 07/28/2017 08:00 EDT | Misc | Merck & Co Inc Second Quarter Earnings Conference Call in 2017 |
| 07/28/2017 | Earnings | Merck & Co Inc Second Quarter Earnings in 2017 Release |
| 06/13/2017 | Dividends | Amount: 0.47, Declared Date: May 23 2017, Pay Date: Jul 10 2017 |
| 05/23/2017 09:00 EDT | Misc | Merck & Co Inc Annual General Meeting in 2016 |
| 05/02/2017 08:00 EDT | Misc | Merck & Co Inc First Quarter Earnings Conference Call in 2017 |
| 05/02/2017 | Earnings | Merck & Co Inc First Quarter Earnings in 2017 Release |
| 03/22/2017 | Misc | Merck Animal Health Completes Acquisition of Vallée s.A. |
| 03/13/2017 | Dividends | Amount: 0.47, Declared Date: Mar 01 2017, Pay Date: Apr 07 2017 |
| 02/02/2017 08:00 EDT | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call in 2016 |
MRK Fundamentals
Income Statement View Statement
MRK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MRK One Page Reports
- One Page Report Download
MRK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 65.61 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.merck.com
- Investor Relations URL: http://investors.merck.com/investors/default.aspx
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: N/A
- Last Earnings Release: Jul. 28, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Sep. 14, 2017
- Description: Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
MRK Comparables
EditMRK Excel Add-In Codes
- Name: =YCI("MRK","name")
- Description: =YCI("MRK","description")
- Sector: =YCI("MRK","sector")
- Industry: =YCI("MRK","industry")
- Est. Current Fiscal Year End: =YCI("MRK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MRK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MRK Tweets Stocktwits
Advertisement
